The project “Research and Development of an Advanced Formulation for Alveolar Ridge Augmentation – OSTEOproDENT” is currently launched.
RESEARCH & DEVELOPMENT
OF AN ADVANCED FORMULATION FOR
ALVEOLAR RIDGE AUGMENTATION
OSTEOproDENT is an innovative biotechnological drug currently in clinical trials, offering a range of unique advantages in the treatment of alveolar ridge augmentation (ARA), and standing out as a novel and safe solution for bone regeneration.
INNOVATIVE FORMULATION
An advanced graft structure is being developed with the aim of achieving stable regeneration even in complex and large defects.
EASY-TO-USE
A fast and simple preparation is anticipated, making it practical for everyday clinical use.
SAFETY
The formulation, free of animal and allogeneic components, reduces the risk of disease transmission and immune reactions.
COST-EFFECTIVENESS
The development is aimed at eliminating secondary surgical procedures, thereby reducing overall costs and treatment duration.
SARTORIUS CROATIA
PROJECT LEADER
GLOBAL
INNOVATION
Backed by patent protection and a global commercialization strategy, OSTEOproDENT represents a significant step forward in dental medicine – with the potential to change the approach to alveolar ridge (ARA) treatment worldwide.
MISSION
Our mission is to develop innovative, biologically-based solutions for bone regeneration in dental medicine, enabling a personalized approach to treatment, improving patient outcomes, and reducing the need for invasive procedures.
VISION
OSTEOproDENT’s vision is to become a global leader in regenerative dental medicine, offering safe, effective, and accessible technologies that redefine standards in alveolar ridge treatment and promote natural tissue restoration.
STRONG PARTNERSHIP
Sartorius Croatia – Libra Elektronik d.o.o., in collaboration with its partners, the University of Zagreb – School of Medicine, Genera Research d.o.o., and the Dental Clinic Dario Bekavac, launched the implementation of the project “Research and Development of an Advanced Formulation for Alveolar Ridge Augmentation – OSTEOproDENT” on January 13, 2025.
FOLLOW RESEARCH & DEVELOPMENT
Stay updated on the progress of the Osteoprodent project!
Share yout contact details to receive the latest news, event invitations, and collaboration opportunities.
